ACADL and non-small cell lung carcinoma: Application of XMU-MP-1 reversed the cytosol accumulation and phosphorylation of YAP induced by ACADL overexpression and partially mitigated the repression of ACADL on cell cycle progress, cell proliferation, and cellular invasion in NSCLC.